Novartis AG said on Thursday it would sell the dermatology and generic US oral solids portfolios of Sandoz US to Aurobindo Pharma Ltd for $900 million, as the Swiss drug maker looks to focus on higher...
from NDTV Profit - Latest https://ift.tt/2M2AW7m
Home / Business /
NDTV Profit - Latest
/ Aurobindo Pharma Buys Parts Of Sandoz US From Novartis For $900 Million
Subscribe to:
Post Comments
(
Atom
)
0 comments:
Post a Comment